NovoCure LimitedNVCRNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
6.17
↓ 66% below average
Average (9y)
18.34
Historical baseline
Range
High:53.33
Low:3.82
CAGR
-21.3%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 6.17 | +61.6% |
| 2023 | 3.82 | -74.8% |
| 2022 | 15.15 | -0.4% |
| 2021 | 15.21 | -57.4% |
| 2020 | 35.74 | +53.4% |
| 2019 | 23.29 | +87.4% |
| 2018 | 12.43 | +21.7% |
| 2017 | 10.21 | +26.7% |
| 2016 | 8.06 | -84.9% |
| 2015 | 53.33 | - |